These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38387951)

  • 1. [Seroepidemiological analysis of hepatitis B virus infection among adolescents aged 0-14 years in Henan Province and preliminary evaluation of the effectiveness of childhood hepatitis B vaccine immunization program].
    Guo YH; Chen YP; Dou QH; Liu Q; Yang JH; Seng MH; Lyu YY; Wang CS; Lu MX; Xu J; Zhang YY; Zhao DY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2024 Feb; 58(2):202-207. PubMed ID: 38387951
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis B immunization status and risk factors of people aged 1 to 69 in Huangpu District, Shanghai, China.
    Wang Y; Shu M; Chen J; Shen F; Ren H; Yu Y
    Front Public Health; 2023; 11():1302183. PubMed ID: 38179572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An epidemiological serosurvey of hepatitis B virus shows evidence of declining prevalence due to hepatitis B vaccination in central China.
    Yonghao G; Jin X; Jun L; Pumei D; Ying Y; Xiuhong F; Yanyang Z; Wanshen G
    Int J Infect Dis; 2015 Nov; 40():75-80. PubMed ID: 26456567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiological serosurvey of hepatitis B virus among children aged 1-14 years in Guangdong Province, China.
    Zhu Q; Shao X; Chen S; Li D; Chen X; Liu W; Wu X; Jian Z; Rutherford S; Zheng H
    Int J Infect Dis; 2018 Jun; 71():25-29. PubMed ID: 29408358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The epidemiological characteristics of HBV susceptibility in 1-29 years old young people in China in 2006 and 2014: based on the national sero-survey data analysis].
    Zheng H; Wang FZ; Zhang GM; Miao N; Sun XJ; Cui FQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jul; 51(7):581-586. PubMed ID: 28693080
    [No Abstract]   [Full Text] [Related]  

  • 6. [Seroepidemiological analysis of hepatitis B among children aged 1-14 in 3 counties of Guangdong province in 2013].
    Shao X; Wu C; Wang F; Liang J; Xie X; Zhu Q; Liu J; Hu P; Qiu Q; Liang X; Zheng H
    Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Sep; 49(9):777-81. PubMed ID: 26733134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of hepatitis B vaccination among children in Guangdong Province, China.
    Xiao J; Zhang J; Wu C; Shao X; Peng G; Peng Z; Ma W; Zhang Y; Zheng H
    Int J Infect Dis; 2012 Sep; 16(9):e692-6. PubMed ID: 22795176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of epidemiological serosurvey of hepatitis B virus among people under 29 years of age in Jiangsu Province, China.
    Sun X; Zhu Y; Tang F; Deng X; Wang Z; Liu Y
    Hum Vaccin Immunother; 2021 Oct; 17(10):3729-3734. PubMed ID: 34096830
    [No Abstract]   [Full Text] [Related]  

  • 9. [Preliminary analysis on the prevalence and causes of breakthrough hepatitis B virus infection among children in Shandong province, China].
    Zhang L; Yan BY; Li MS; Song LZ; Lü JJ; Xu Q; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Oct; 47(10):933-9. PubMed ID: 24378135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-HBs persistence following revaccination with three doses of hepatitis B vaccine among low-responsive adults after primary vaccination: a 4-year follow-up study].
    Lyu JJ; Yin XW; Yan BY; Liu JY; Feng Y; Wu WL; Chen SY; Zhou LB; Liang XF; Cui FQ; Wang FZ; Zhang L; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jun; 50(6):491-6. PubMed ID: 27256727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anti-HBs persistence after revaccination with three doses of hepatitis B vaccine among non-responsive adults: a 4-year of follow-up study].
    Zhang L; Yan BY; Lyu JJ; Liu JY; Feng Y; Wu WL; Cao CZ; Chen SY; Zhou LB; Liang XF; Cui FQ; Wang FZ; Zhang GM; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jun; 50(6):497-502. PubMed ID: 27256728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant reduction in notification and seroprevalence rates of hepatitis B virus infection among the population of Zhejiang Province, China, aged between 1 and 29years from 2006 to 2014.
    Zhou Y; He H; Deng X; Yan R; Tang X; Xie S; Yao J
    Vaccine; 2017 Aug; 35(34):4355-4361. PubMed ID: 28687404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative analyze on hepatitis B seroepidemiological surveys among population aged 1-29 years in different epidemic regions of China in 1992 and 2014].
    Wang FZ; Zhang GM; Shen LP; Zheng H; Wang F; Miao N; Yuan QL; Sun XJ; Bi SL; Liang XF; Wang HQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jun; 51(6):462-468. PubMed ID: 28592086
    [No Abstract]   [Full Text] [Related]  

  • 14. Protective effect of vaccinating infants with a 5 µg recombinant yeast-derived hepatitis B vaccine and the need for a booster dose in China.
    Miao N; Zheng H; Sun X; Zhang G; Wang F
    Sci Rep; 2020 Oct; 10(1):18155. PubMed ID: 33097788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-HBs persistence following primary vaccination with three doses of hepatitis B vaccine among normal and high-responder adults: a 3-year follow-up study].
    Lyu JJ; Zhang L; Yan BY; Liu JY; Feng Y; Song LZ; Chen SY; Zhou LB; Liang XF; Cui FQ; Wang FZ; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jun; 50(6):478-83. PubMed ID: 27256725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroepidemiological study of hepatitis B virus markers in Japan.
    Kiyohara T; Ishii K; Mizokami M; Sugiyama M; Wakita T
    Vaccine; 2015 Nov; 33(45):6037-42. PubMed ID: 26341564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibody persistence following booster vaccination with three doses of hepatitis B vaccines among low-response adults in Zhangqiu county of Shandong province: 24-month of follow-up from 2009].
    Yan B; Lyu J; Liu J; Feng Y; Xu A; Chen S; Zhou L; Liang X; Cui F; Wang F; Zhang L
    Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Dec; 48(12):1043-7. PubMed ID: 25619213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term efficacy of infant hepatitis B immunization program].
    Gong J; Li RC; Yang JY; Li YP; Chen XR; Xu ZY; Liu CB; Cao HL; Zhao K; Ni DM
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):203-5. PubMed ID: 12716514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the impact of the routine childhood hepatitis B immunization program and the need for hepatitis B vaccine birth dose in Sierra Leone, 2018.
    Breakwell L; Marke D; Kaiser R; Tejada-Strop A; Pauly MD; Jabbi S; Yambasu S; Kabore HJ; Stewart B; Sesay T; Samba TT; Hayden T; Kamili S; Jambai A; Drobeniuc J; Singh T; Tohme RA; Wasley A
    Vaccine; 2022 Apr; 40(19):2741-2748. PubMed ID: 35361502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effectiveness of 20 μg hepatitis B vaccine used for the prevention of HBV vertical transmission.
    Yonghao G; Yanping C; Qiaohua D; Daxing F; Yanyang Z; Dongyang Z; Wanshen G
    Sci Rep; 2022 Jul; 12(1):11759. PubMed ID: 35817837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.